OR WAIT 15 SECS
The new ingredient combination from Mineral BioSciences combines its Totala ionic mineral complex with vitamin D3.
GlyDe D, a new ingredient combination from Mineral BioSciences (Phoenix), is designed to help people manage their blood sugar by lowering levels of glycated hemoglobin (A1C). Short for “glycation defense,” GlyDe D combines vitamin D3 with the company’s proprietary Totala ionic mineral complex ingredient.
Harmful rogue molecules called advanced glycation end-products (AGEs) are formed through the glycation process when excess sugar molecules bond with protein, but Mineral BioSciences says its Totala complex helps protect tissues against glycation and thwart the formation of AGEs. By disrupting the glycation process, clinical studies have suggested GlyDe D may be able to help lower blood glucose and reduce glycated hemoglobin levels, as well as reduce oxidative stress, according to Mineral BioSciences.
Additionally, Vitamin D3 is included in GlyDe D because people living with low blood sugar levels are often lacking in the important nutrient, which may help boost the production of genes that destroy viruses, bacteria, and other germs, says the company.
“GlyDe D is an innovative product that will become a game changer for individuals who want help managing their blood sugar naturally,” says Luke Blotsky, managing partner and CEO, Mineral BioSciences. “It meets and exceeds industry challenges by being a sustainable solution to a growing problem that a lot of people are not finding an easy solution for.”
GlyDe D is currently available for purchase online in softgel form, and it is meant to be taken once or twice a day following meals. The new blood sugar control ingredient, which is also Generally Recognized as Safe (GRAS) by FDA, will be available in select retail stores in early 2016.
Nutritional Outlook Magazine